MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...

Ketamir-2 Demonstrates Strong Efficacy in Diabetic Neuropathy Model, with Some Subjects Achieving Complete Symptom Reversal ...

How the heck is a brand new startup worth $10 billion? Here are 2 explanations that revolve around how VC funds and Big Tech ...

Former OpenAI Chief Tech Officer Mira Murati’s AI startup, Thinking Machines, is looking to raise a massive $2 billion seed ...

Ex-OpenAI CTO Mira Murati's new AI venture, Thinking Machines Lab, has gained two new prominent advisers, Bob McGrew and Alec ...

Bob McGrew was quietly added to Thinking Machines Lab's website as an advisor, alongside former OpenAI researcher Alec ...